Solventum (SOLV) to Release Earnings on Thursday

Solventum (NYSE:SOLV - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results after the market closes on Thursday, May 8th. Analysts expect Solventum to post earnings of $1.19 per share and revenue of $2.02 billion for the quarter.

Solventum Trading Down 1.0 %

Shares of Solventum stock traded down $0.65 during trading on Tuesday, reaching $66.24. The company's stock had a trading volume of 76,857 shares, compared to its average volume of 1,120,771. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum has a 52-week low of $47.16 and a 52-week high of $85.92. The firm's 50-day moving average is $71.25 and its two-hundred day moving average is $71.42. The company has a market cap of $11.46 billion and a price-to-earnings ratio of 24.07.

Analyst Ratings Changes

SOLV has been the topic of a number of recent research reports. Piper Sandler reduced their price objective on Solventum from $84.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Bank of America increased their price target on shares of Solventum from $80.00 to $85.00 and gave the company a "neutral" rating in a research report on Wednesday, February 26th. The Goldman Sachs Group increased their price objective on Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a report on Monday, March 3rd. Wells Fargo & Company raised their target price on Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a research note on Friday, February 28th. Finally, Mizuho upped their price target on Solventum from $70.00 to $82.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $79.29.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.